首页> 美国卫生研究院文献>Brazilian Journal of Medical and Biological Research >Ischemic preconditioning vs adenosine vs prostaglandin E1 for protection against liver ischemia/reperfusion injury
【2h】

Ischemic preconditioning vs adenosine vs prostaglandin E1 for protection against liver ischemia/reperfusion injury

机译:缺血预处理腺苷和前列腺素E1可以预防肝缺血/再灌注损伤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ischemia/reperfusion injury is still a major cause of morbidity and mortality during liver surgery and transplantation. A variety of surgical and pharmacological therapeutic strategies have been investigated to minimize the effects of ischemia/reperfusion. The aim of our study was to analyze and compare preventive influences of ischemic preconditioning, adenosine and prostaglandin E1 in the experimental model of hepatic ischemia/reperfusion injury. Adult chinchilla rabbits were divided into four groups: 10 rabbits subjected to liver ischemic preconditioning (3-min period of inflow occlusion followed by a 5-min period of reperfusion) followed by 45 min of Pringle maneuver; 10 rabbits subjected to pre-treatment with intraportal injection of adenosine followed by 45 min of Pringle maneuver; 10 rabbits subjected to pre-treatment with intraportal injection of prostaglandin E1 followed by 45 min of Pringle maneuver; and control group of 10 rabbits subjected to 45 min of inflow liver ischemia without any preconditioning. On the second postoperative day, blood samples were obtained and biochemical parameters of liver function were measured and compared. Liver tissue samples were also obtained and histopathological changes were compared. Based on biochemical and histopathological parameters, it was demonstrated that ischemic preconditioning provided the best protection against hepatic ischemia/reperfusion injury. This was probably due to a wider range of mechanisms of action of this method oriented to reduce oxidative stress and inflammation, and restore liver microcirculation and hepatocyte energy compared to the examined pharmacological strategies.
机译:缺血/再灌注损伤仍是肝脏手术和移植过程中发病率和死亡率的主要原因。为了最小化缺血/再灌注的影响,已经研究了多种外科和药理学治疗策略。本研究的目的是分析和比较缺血预处理,腺苷和前列腺素E1在肝缺血/再灌注损伤实验模型中的预防作用。将成年黄鼠兔子分为四组:10只兔子进行了肝脏缺血预处理(3分钟的血流闭塞,再灌注5分钟的血流灌注),然后进行45分钟的普林格尔动作; 10只兔子接受腺苷门静脉内注射预处理,然后进行45分钟的Pringle动作;对10只兔进行门静脉内注射前列腺素E1的预处理,然后进行45分钟的普灵格尔操作;对照组的10只兔子在未进行任何预处理的情况下进行了45分钟的流入肝脏缺血。术后第二天,采集血样,测量并比较肝功能的生化指标。还获得了肝组织样品并比较了组织病理学变化。基于生化和组织病理学参数,已证明缺血预处理可提供最佳保护,防止肝缺血/再灌注损伤。与所研究的药理策略相比,这可能是由于该方法的作用机理范围更广,旨在减少氧化应激和炎症,并恢复肝脏微循环和肝细胞能量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号